Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.

Compound 1 was identified by high throughput screening as a novel, potent, non-amidine factor Xa inhibitor with good selectivity against thrombin and trypsin. A series of modifications of the three aromatic groups of 1 was investigated. Substitution of chlorine or bromine for fluorine on the aniline ring led to the discovery of subnanomolar factor Xa inhibitors. Positions on the anthranilic acid ring that can accommodate further substitution were also identified.

[1]  H. Ishihara,et al.  DX-9065a, an Orally Active, Specific Inhibitor of Factor Xa, Inhibits Thrombosis without Affecting Bleeding Time in Rats , 1995, Thrombosis and Haemostasis.

[2]  P. Sprengeler,et al.  Perspectives on factor Xa inhibition. , 2001, Current medicinal chemistry.

[3]  D. Smith,et al.  Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor Xa. , 1990, Biochemistry.

[4]  P. Sprengeler,et al.  Neutral inhibitors of the serine protease factor Xa. , 2001, Bioorganic & medicinal chemistry letters.

[5]  J. Vacca.  New advances in the discovery of thrombin and factor Xa inhibitors. , 2000, Current opinion in chemical biology.

[6]  S. Hanson,et al.  Antithrombotic Benefits and Hemorrhagic Risks of Direct Thrombin Antagonists , 1995, Thrombosis and Haemostasis.

[7]  P. Sanderson.  Chapter 8. Anticoagulants: Inhibitors of thrombin and factor Xa , 2001 .

[8]  J. Vacca,et al.  Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy. , 1997, Journal of medicinal chemistry.

[9]  W. R. Ewing,et al.  PROGRESS IN THE DESIGN OF INHIBITORS OF COAGULATION FACTOR XA , 1999 .

[10]  Kenneth G. Mann,et al.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes , 1990 .

[11]  B. Zhu,et al.  Chapter 9. Factor Xa inhibitors: Recent advances in anticoagulant agents , 2000 .

[12]  J F Morrison,et al.  Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. , 1969, Biochimica et biophysica acta.

[13]  J. A. Kyle,et al.  N(2)-Aroylanthranilamide inhibitors of human factor Xa. , 2000, Journal of medicinal chemistry.

[14]  J. A. Kyle,et al.  1,2-Dibenzamidobenzene inhibitors of human factor Xa. , 2000, Journal of medicinal chemistry.

[15]  J. T. Metz,et al.  Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity. , 2000, Journal of medicinal chemistry.

[16]  P. Walsh,et al.  Components and Assembly of the Factor X Activating Complex , 1992, Seminars in thrombosis and hemostasis.

[17]  P. Coleman,et al.  Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. , 1981, Methods in enzymology.